Understanding the role of long-acting muscarinic antagonists in asthma treatment

Annals of Allergy, Asthma & Immunology(2022)

引用 6|浏览2
暂无评分
摘要
Long-acting muscarinic antagonists add-on therapy to ICS-LABA improves lung function, reduces exacerbations, and modestly improves asthma control in patients with moderate to severe asthma who are uncontrolled despite the use of ICS-LABA. Long-acting muscarinic antagonists are effective in all asthma phenotypes and endotypes.
更多
查看译文
关键词
Asthma,Bronchodilators,Exacerbations,Muscarinic antagonists,Muscarinic receptors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要